From genetic screens to therapies against neurodegeneration

ISAB unites molecular biology, neuroscience, and translational medicine to discover actionable targets against prion diseases, Parkinson’s disease, and related proteinopathies.

Explore our science

The ISAB logo is fashioned in green, the official color of the Canton of St. Gallen. The shield symbolizes the protection of the brain and the pursuit of knowledge. The ribbon represents an alpha-helical protein antithetical to the misfolded proteins that cause neurodegenerative diseases.

This test version is password-protected.

Prion research

We dissect prion replication, spread, and toxicity using unbiased CRISPR genomic screens, advanced cell models, and organotypic brain cultures.

Read the chapter →

Parkinson’s disease

We identify genetic modifiers of α-synuclein pathology using high-throughput screening approaches in human cellular models of disease.

Read the chapter →

Cloning human antibodies

We map autoantibodies at scale and validate antigen-specific responses in large cohorts to discover protective human antibodies that can be used therapeutically.

Read the chapter →

Unbiased genetic screens

We have constructed genome-wide, unbiased CRISPR arrayed libraries to interrogate biochemical, morphological, and cell-nonautonomous phenotypes that are inaccessible to pooled approaches.

Read the chapter →